Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Peritoneal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05198804
What this trial is testing

Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerPlatinum-resistant Ovarian CancerPrimary Peritoneal Carcinoma+1 more
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 117
Testing effectiveness (Phase 2)Study completedNCT00061477
What this trial is testing

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 48
Not applicableStudy completedNCT01982500
What this trial is testing

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Oncology Research Group 200
Large-scale testing (Phase 3)Looking for participantsNCT06994195
What this trial is testing

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 450
Early research (Phase 1)Study completedNCT02303912
What this trial is testing

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Imperial College Healthcare NHS Trust 25
Testing effectiveness (Phase 2)Ended earlyNCT00903630
What this trial is testing

Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Ended earlyNCT02900560
What this trial is testing

Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Translational Research in Oncology 34
Large-scale testing (Phase 3)Looking for participantsNCT05303714
What this trial is testing

PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer

Who this might be right for
Oligometastatic Gastric Adenocarcinoma
Azienda Ospedaliera Universitaria Integrata Verona 98
Large-scale testing (Phase 3)Study completedNCT02477644
What this trial is testing

Platine, Avastin and OLAparib in 1st Line

Who this might be right for
Ovarian Cancer
Arcagy Research 806
Testing effectiveness (Phase 2)Study completedNCT00059787
What this trial is testing

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790706
What this trial is testing

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Who this might be right for
Peritoneal MesotheliomaGestational Trophoblastic TumorAnaplastic Thyroid Carcinomas+3 more
Hospices Civils de Lyon 27
Testing effectiveness (Phase 2)UnknownNCT06487715
What this trial is testing

Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer Peritoneal Metastases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 42
Testing effectiveness (Phase 2)Looking for participantsNCT05200260
What this trial is testing

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 220
Not applicableStudy completedNCT02295982
What this trial is testing

Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence)

Who this might be right for
Renal Cancer
Zealand University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01570582
What this trial is testing

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
Korean Gynecologic Oncology Group 314
Testing effectiveness (Phase 2)Active Not RecruitingNCT01843374
What this trial is testing

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

Who this might be right for
Unresectable Pleural or Peritoneal Malignant Mesothelioma
MedImmune LLC 571
Not applicableUnknownNCT04122885
What this trial is testing

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Who this might be right for
Peritoneal CancerChemotherapy-Induced Change
University Hospital Tuebingen 60
Not applicableStudy completedNCT02228889
What this trial is testing

RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction

Who this might be right for
Hernia, VentralIntestinal FistulaFibromatosis, Abdominal
Jeffrey Janis 46
Testing effectiveness (Phase 2)Study completedNCT00193297
What this trial is testing

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovary Cancer
SCRI Development Innovations, LLC 50
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Next Page